Cargando…
Increased tumor glycolysis is associated with decreased immune infiltration across human solid tumors
Response to immunotherapy across multiple cancer types is approximately 25%, with some tumor types showing increased response rates compared to others (i.e. response rates in melanoma and non-small cell lung cancer (NSCLC) are typically 30-60%). Patients whose tumors are resistant to immunotherapy o...
Autores principales: | Cohen, Ivan J., Pareja, Fresia, Socci, Nicholas D., Shen, Ronglai, Doane, Ashley S., Schwartz, Jazmin, Khanin, Raya, Morris, Elizabeth A., Sutton, Elizabeth J., Blasberg, Ronald G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731115/ https://www.ncbi.nlm.nih.gov/pubmed/36505421 http://dx.doi.org/10.3389/fimmu.2022.880959 |
Ejemplares similares
-
Impact of the Tumor Microenvironment on Tumor-Infiltrating Lymphocytes: Focus on Breast Cancer
por: Cohen, Ivan J, et al.
Publicado: (2017) -
LDH-A regulates the tumor microenvironment via HIF-signaling and modulates the immune response
por: Serganova, Inna, et al.
Publicado: (2018) -
Perspectives of tumor-infiltrating lymphocyte treatment in solid tumors
por: Wang, Shuhang, et al.
Publicado: (2021) -
Response to Zhou and Robinson
por: Betel, Doron, et al.
Publicado: (2015) -
CD28 costimulation drives tumor-infiltrating T cell glycolysis to promote inflammation
por: Beckermann, Kathryn E., et al.
Publicado: (2020)